Literature DB >> 17955593

Once daily drop regimes help reduce involuntary non-compliance.

John Cameron Buchan, Salina Siddiqui, David Gilmour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17955593     DOI： 10.1007/s00417-006-0438-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  1 in total

1.  Patients prefer once-daily glaucoma drops.

Authors:  Alex J Buller; Laurence H Morgan; Brian L Hercules
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117
  1 in total
  2 in total

1.  The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice.

Authors:  Elizabeth A Cairns; Anna-Maria Szczesniak; Alex J Straiker; Pushkar M Kulkarni; Roger G Pertwee; Ganesh A Thakur; William H Baldridge; Melanie E M Kelly
Journal:  J Ocul Pharmacol Ther       Date:  2017-07-18       Impact factor: 2.671

2.  Noncompliance with Ocular Hypertensive Treatment in Patients with Primary Open Angle Glaucoma among the Arab Population in Israel: A Cross-Sectional Descriptive Study.

Authors:  Muhannad Masoud; Adi Sharabi-Nov; Joseph Pikkel
Journal:  J Ophthalmol       Date:  2013-07-01       Impact factor: 1.909
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.